PhRMA Deal Intact As Senate Health Reform Bill Enters Home Stretch

The $80 billion deal struck last spring between the White House, Senate Finance Committee Chairman Max Baucus, D-Mont., and the Pharmaceutical Research and Manufacturers of America remained in force as the full Senate moved toward the end of its third week of debating the bill